NXS 7.69% 21.0¢ next science limited

This isn't a David and Goliath battle it's David and...

  1. 142 Posts.
    lightbulb Created with Sketch. 33
    This isn't a David and Goliath battle it's David and Godzilla...or maybe bigger. ZB's speciality is orthopeadics, right in NXS's currently desired sweetspot. Hate to have to say it, but they're someone you would want to have a good relationship with because they're one of the major players, I think third by revenue in this space 2 or 3 years ago. The largest by revenue was Stryker, and then Depuy Synthes (according to the article below). Interesting article here about the industry and it's ongoing purchasing of much needed tecchnology. DYOR

    https://www.odtmag.com/issues/2019-08-14/view_features/the-2019-top-10-global-orthopedic-device-firms-955005/
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
21.0¢
Change
0.015(7.69%)
Mkt cap ! $61.25M
Open High Low Value Volume
20.0¢ 21.0¢ 20.0¢ $3.624K 17.75K

Buyers (Bids)

No. Vol. Price($)
5 80261 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.0¢ 7325 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.